The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Mechanisms of Anthracycline Cardiac Injury: Can We Identify Strategies for Cardioprotection?
Open accessAbstract
Summary Anthracycline antibiotics have saved the lives of many cancer victims in the 50 plus years since their discovery. A major limitation of their use is the dose-limiting cardiotoxicity. Efforts focusing on understanding the biochemical basis for anthracycline cardiac effects have provided several strategies currently in clinical use: limit dose exposure; encapsulate anthracyclines in liposomes to reduce myocardial uptake; administer concurrently with the iron chelator dexrazoxane to reduce free iron-catalyzed reactive oxygen species formation; modification of anthracycline structure in an effort to reduce myocardial toxicity. In spite of these efforts, anthracycline-induced heart failure continues to occur with consequences for both morbidity and mortality. Our inability to predict and prevent anthracycline cardiotoxicity is in part due to the fact that the molecular and cellular mechanisms remain controversial and incompletely understood. Studies examining the effects of anthracyclines in cardiac myocytes in vitro and small animals in vivo have demonstrated several forms of cardiac injury, and it remains unclear how these translate to the clinical setting. Given the clinical evidence that myocyte death occurs after anthracycline exposure in the form of elevations in serum troponin, myocyte cell death appears to be a probable mechanism for anthracycline-induced cardiac injury. Other mechanisms of myocyte injury include the development of cellular ‘sarcopenia’ characterized by disruption of normal sarcomere structure. Anthracyclines suppress expression of several cardiac transcription factors, and this may play a role in the development of myocyte death as well as sarcopenia. Degradation of the giant myofilament protein titin may represent an important proximal step that leads to accelerated myofilament degradation. An interesting interaction has been noted clinically between anthracyclines and newer cancer therapies that target the erbB2 receptor tyrosine kinase. There is now evidence that erbB2 signaling in response to the ligand neuregulin regulates anthracycline uptake into cells via the multidrug-resistance protein. Therefore upregulation of cardiac neuregulin signaling may be one strategy to limit myocardial anthracycline injury. Moreover, assessing an individual’s risk for anthracycline injury may be improved by having some measure of endogenous activity of this and other myocardial protective signals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Suliman, H. B., Carraway, M. S., Ali, A. S., Reynolds, C. M., Welty-Wolf, K. E., & Piantadosi, C. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32967 · Cited by 257
RetractedSlamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,287
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778
Swain, S. M., Whaley, F. S., & Ewer, M. S. (2003) · Cancer · doi:10.1002/cncr.11407 · Cited by 2,313
Gewirtz, D. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00307-4 · Cited by 2,240
Lamon, D. E. J. S., Eyland, B. R. L., Hak, S. T. S., Uchs, H. A. F., Aton, V. I. P., Ajamonde, A. L. B., LeMing, T., Iermann, W. O. E., Olter, J. A. W., Egram, M. A. P., et al. (2009) · Cited by 1,199
Anthracycline-Induced Cardiomyopathy
Cardinale, D., Colombo, A., Lamantia, G., Colombo, N., Civelli, M., De Giacomi, G., Rubino, M., Veglia, F., Fiorentini, C., & Cipolla, C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.095 · Cited by 1,105
ErbB2 is essential in the prevention of dilated cardiomyopathy
Crone, S. A., Zhao, Y.-Y., Fan, L., Gu, Y., Minamisawa, S., Liu, Y., Peterson, K. L., Chen, J., Kahn, R., Condorelli, G., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-459 · Cited by 903
Wiseman, M. (2008) · Proceedings of the Nutrition Society · doi:10.1017/s002966510800712x · Cited by 899
Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion
LEGHA, S. S., BENJAMIN, R. S., MACKAY, B., EWER, M., WALLACE, S., VALDIVIESO, M., RASMUSSEN, S. L., BLUMENSCHEIN, G. R., & FREIREICH, E. J. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-2-133 · Cited by 763
Ewer, M. S., Vooletich, M. T., Durand, J.-B., Woods, M. L., Davis, J. R., Valero, V., & Lenihan, D. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.300 · Cited by 726
Matsui, T., Tao, J., del Monte, F., Lee, K.-H., Li, L., Picard, M., Force, T. L., Franke, T. F., Hajjar, R. J., & Rosenzweig, A. (2001) · Circulation · doi:10.1161/01.cir.104.3.330 · Cited by 701
Doxorubicin cardiotoxicity: analysis of prevailing hypotheses
Olson, R. D., & Mushlin, P. S. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.13.2210154 · Cited by 690
Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).
Sliwkowski, M. X., Ja, L., Gd, L., Te, H., FENDLY, B. M., & Fox, J. A. (1999) · PubMed · Cited by 653
Lipshultz, S. E., Rifai, N., Dalton, V. M., Levy, D. E., Silverman, L. B., Lipsitz, S. R., Colan, S. D., Asselin, B. L., Barr, R. D., Clavell, L. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035153 · Cited by 623
(2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00136.x · Cited by 593
Segal, R., Evans, W., Johnson, D., Smith, J., Colletta, S., Gayton, J., Woodard, S., Wells, G., & Reid, R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.657 · Cited by 576
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60784-8 · Cited by 540
Childs, A. C., Phaneuf, S., Dirks, A. J., Phillips, T., & Leeuwenburgh, C. (2002) · PubMed · Cited by 525
Neuregulins Promote Survival and Growth of Cardiac Myocytes
Zhao, Y.-Y., Sawyer, D. R., Baliga, R. R., Opel, D. J., Han, X., Marchionni, M. A., & Kelly, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10261 · Cited by 504
Self-citationAcute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis.
Arola, O., Saraste, A., Pulkki, K. J., Kallajoki, M. A., Parvinen, M., & Voipio-Pulkki, L. M. (2000) · PubMed · Cited by 494
Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy
Özcelik, C., Erdmann, B., Pilz, B., Wettschureck, N., Britsch, S., Hübner, N., Chien, K. R., Birchmeier, C., & Garratt, A. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122249299 · Cited by 473
ER stress in cardiovascular disease
Minamino, T., & Kitakaze, M. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.10.026 · Cited by 460
Home-Based Physical Activity Intervention for Breast Cancer Patients
Pinto, B. M., Frierson, G. M., Rabin, C., Trunzo, J. J., & Marcus, B. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.080 · Cited by 460
Yen, H. C., Oberley, T. D., Vichitbandha, S., Ho, Y. S., & St Clair, D. K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118909 · Cited by 459
Predictive Value of Cardiac Troponin T in Pediatric Patients at Risk for Myocardial Injury
Lipshultz, S. E., Rifai, N., Sallan, S. E., Lipsitz, S. R., Dalton, V., Sacks, D. B., & Ottlinger, M. E. (1997) · Circulation · doi:10.1161/01.cir.96.8.2641 · Cited by 384
Exercise manages fatigue during breast cancer treatment: A randomized controlled trial
Mock, V., Frangakis, C., Davidson, N. E., Ropka, M. E., Pickett, M., Poniatowski, B., Stewart, K. J., Cameron, L., Zawacki, K., Podewils, L. J., et al. (2005) · Psycho-Oncology · doi:10.1002/pon.863 · Cited by 382
Anthracyclines Induce Calpain-dependent Titin Proteolysis and Necrosis in Cardiomyocytes
Lim, C. C., Zuppinger, C., Guo, X., Kuster, G. M., Helmes, M., Eppenberger, H. M., Suter, T. M., Liao, R., & Sawyer, D. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308033200 · Cited by 304
Self-citationEarly and delayed clinical cardiotoxicity of doxorubicin
Buzdar, A. U., Marcus, C., Blumenschein, G. R., & Smith, T. L. (1985) · Cancer · doi:10.1002/1097-0142(19850615)55:12<2761::aid-cncr2820551206>3.0.co;2-p · Cited by 300
Bang, M.-L., Mudry, R. E., McElhinny, A. S., Trombitás, K., Geach, A. J., Yamasaki, R., Sorimachi, H., Granzier, H., Gregorio, C. C., & Labeit, S. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.2.413 · Cited by 296
Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity
Aries, A., Paradis, P., Lefebvre, C., Schwartz, R. J., & Nemer, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401833101 · Cited by 296
Sawyer, D. B., Zuppinger, C., Miller, T. A., Eppenberger, H. M., & Suter, T. M. (2002) · Circulation · doi:10.1161/01.cir.0000013839.41224.1c · Cited by 292
Self-citationNeuregulins are concentrated at nerve-muscle synapses and activate ACh–receptor gene expression
Ahn Jo, S., Zhu, X., Marchionni, M. A., & Burden, S. J. (1995) · Nature · doi:10.1038/373158a0 · Cited by 277
Kunisada, K., Negoro, S., Tone, E., Funamoto, M., Osugi, T., Yamada, S., Okabe, M., Kishimoto, T., & Yamauchi-Takihara, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.315 · Cited by 273
Titin Develops Restoring Force in Rat Cardiac Myocytes
Helmes, M., Trombita´s, K., & Granzier, H. (1996) · Circulation Research · doi:10.1161/01.res.79.3.619 · Cited by 260
GATA transcription factors and cardiac development
Charron, F., & Nemer, M. (1999) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.1998.0281 · Cited by 258
Ito, H., Miller, S. C., Billingham, M. E., Akimoto, H., Torti, S. V., Wade, R., Gahlmann, R., Lyons, G., Kedes, L., & Torti, F. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4275 · Cited by 255
Rajagopalan, S., Politi, P. M., Sinha, B. K., & Myers, C. E. (1988) · PubMed · Cited by 248
Cooperative Interaction between GATA-4 and GATA-6 Regulates Myocardial Gene Expression
Charron, F., Paradis, P., Bronchain, O., Nemer, G., & Nemer, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4355 · Cited by 243
Fukazawa, R. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.09.012 · Cited by 238
Essential Roles of Her2/erbB2 in Cardiac Development and Function
Negro, A. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.1 · Cited by 220
A Novel Cardiac-Restricted Target for Doxorubicin
Jeyaseelan, R., Poizat, C., Baker, R. K., Abdishoo, S., Isterabadi, L. B., Lyons, G. E., & Kedes, L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22800 · Cited by 217
Daunorubicin-Induced Apoptosis in Rat Cardiac Myocytes Is Inhibited by Dexrazoxane
Sawyer, D. B., Fukazawa, R., Arstall, M. A., & Kelly, R. A. (1999) · Circulation Research · doi:10.1161/01.res.84.3.257 · Cited by 207
Self-citationEffect of exercise training on antioxidant enzymes and cardiotoxicity of doxorubicin
Kanter, M. M., Hamlin, R. L., Unverferth, D. V., Davis, H. W., & Merola, A. J. (1985) · Journal of Applied Physiology · doi:10.1152/jappl.1985.59.4.1298 · Cited by 202
Analyses of the Molecular Mechanism of Adriamycin-Induced Cardiotoxicity
Gille, L., & Nohl, H. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00025-7 · Cited by 197
Kim, Y., Ma, A.-G., Kitta, K., Fitch, S. N., Ikeda, T., Ihara, Y., Simon, A. R., Evans, T., & Suzuki, Y. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.368 · Cited by 188
Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene
Grillot, D. A., González-García, M., Ekhterae, D., Duan, L., Inohara, N., Ohta, S., Seldin, M. F., & Nuñez, G. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4750 · Cited by 186
Hypoxia/Reoxygenation Stimulates Jun Kinase Activity Through Redox Signaling in Cardiac Myocytes
Laderoute, K. R., & Webster, K. A. (1997) · Circulation Research · doi:10.1161/01.res.80.3.336 · Cited by 174
Swain, S. M., & Vici, P. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0498-7 · Cited by 155
Trastuzumab in the Treatment of Metastatic Breast Cancer
Feldman, A. M., Lorell, B. H., & Reís, S. E. (2000) · Circulation · doi:10.1161/01.cir.102.3.272 · Cited by 152
Fogli, S., Nieri, P., & Breschi, M. C. (2004) · The FASEB Journal · doi:10.1096/fj.03-0724rev · Cited by 134
Wiseman, L. R., & Spencer, C. M. (1998) · Drugs · doi:10.2165/00003495-199856030-00009 · Cited by 132
Petrich, B. G., & Wang, Y. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2003.11.002 · Cited by 132
Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure.
Zhang, W., Elimban, V., NIJJAR, M. S., Gupta, S. K., & Dhalla, N. S. (2003) · PubMed · Cited by 131
Peng, X. (2005) · Molecular Interventions · doi:10.1124/mi.5.3.6 · Cited by 131
Self-citationMolecular Mechanisms of Doxorubicin-induced Cardiomyopathy
Jeyaseelan, R., Poizat, C. I., Wu, H., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5828 · Cited by 131
Cardiac hypertrophy: Targeting Raf/MEK/ERK1/2-signaling
Lorenz, K., Schmitt, J. P., Vidal, M., & Lohse, M. J. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.08.002 · Cited by 128
Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure
Liu, F.-F., Stone, J. R., Schuldt, A. J. T., Okoshi, K., Okoshi, M. P., Nakayama, M., Ho, K. K. L., Manning, W. J., Marchionni, M. A., Lorell, B. H., et al. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00268.2005 · Cited by 128
Jang, Y. M., Kendaiah, S., Drew, B., Phillips, T., Selman, C., Julian, D. A., & Leeuwenburgh, C. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.053 · Cited by 126
The type I growth factor receptors in human breast cancer
Rajkumar, T., & Gullick, W. J. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666177 · Cited by 123
Mode of action of topoisomerase II-targeting agents at a specific DNA sequence
Sørensen, B. S., Sinding, J., Andersen, A. H., Alsner, J., Jensen, P. B., & Westergaard, O. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90863-f · Cited by 122
Titin Determines the Frank-Starling Relation in Early Diastole
Helmes, M., Lim, C. C., Liao, R., Bharti, A. K., Cui, L., & Sawyer, D. B. (2003) · The Journal of General Physiology · doi:10.1085/jgp.20028652 · Cited by 116
Self-citationProteasome-Mediated Degradation of the Coactivator p300 Impairs Cardiac Transcription
Poizat, C. I., Sartorelli, V., Chung, G., Kloner, R. A., & Kedes, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8643-8654.2000 · Cited by 108
Regulation of neuregulin/ErbB signaling by contractile activity in skeletal muscle
LeBrasseur, N. K., Cote, G. M., Miller, T. A., Fielding, R. A., & Sawyer, D. B. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00487.2002 · Cited by 103
Self-citationMortensen, S., Olsen, H., & Baandrup, U. T. (1986) · Heart · doi:10.1136/hrt.55.3.274 · Cited by 100
Relation of exercise to the recurrence rate of myocardial infarction in men
Rechnitzer, P. A., Cunningham, D. A., Andrew, G. M., Buck, C. W., Jones, N. L., Kavanagh, T., Oldridge, N., Parker, J. O., Shephard, R. J., Sutton, J. R., et al. (1983) · The American Journal of Cardiology · doi:10.1016/s0002-9149(83)80012-5 · Cited by 96
Hong, F., Kwon, S., Jhun, B. S., Kim, S. S., Ha, J., Kim, S.-J., Sohn, N. W., Kang, C., & Kang, I. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)01012-2 · Cited by 95
Exercise as a coronary protective factor
Chandrashekhar, Y., & Anand, I. S. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90290-x · Cited by 90
Assessment of Anthracycline Cardiomyopathy by Endomyocardial Biopsy
Mackay, B., Ewer, M. S., Carrasco, C. H., & Benjamin, R. S. (1994) · Ultrastructural Pathology · doi:10.3109/01913129409016291 · Cited by 84
Tokarska-Schlattner, M., Wallimann, T., & Schlattner, U. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.3.516 · Cited by 75
Intervention of adriamycin induced free radical damage.
Balanehru, S., & Nagarajan, B. (1992) · PubMed · Cited by 68
ARC is a critical cardiomyocyte survival switch in doxorubicin cardiotoxicity
An, J., Li, P., Li, J., Dietz, R., & Donath, S. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0434-z · Cited by 66
Strategic advantages of insulin‐like growth factor‐I expression for cardioprotection
Chao, W., Matsui, T., Novikov, M. S., Tao, J., Li, L., Liu, H., Ahn, Y., & Rosenzweig, A. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.347 · Cited by 65
Pouna, P., Bonoron‐Adèle, S., Gouverneur, G., Tariosse, L., Besse, P., & Robert, J. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15326.x · Cited by 62
Regulation of cardiac myocyte apoptosis by the GATA-4 transcription factor
Suzuki, Y., & Evans, T. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.10.002 · Cited by 59
Thermal preconditioning protects rat cardiac muscle cells from doxorubicin-induced apoptosis
Ito, H., Shimojo, T., Fujisaki, H., Tamamori, M., Ishiyama, S., Adachi, S., Abe, S., Marumo, F., & Hiroe, M. (1999) · Life Sciences · doi:10.1016/s0024-3205(98)00617-1 · Cited by 56
Peroxynitrite-induced inhibition and nitration of cardiac myofibrillar creatine kinase
Mihm, M. J., & Bauer, J. A. (2002) · Biochimie · doi:10.1016/s0300-9084(02)00005-6 · Cited by 55
Autophagy in the myocardium: Dying for survival?
Goswami, S. K., & Das, D. K. (2006) · PubMed · Cited by 42
Regulation of myocardial heat shock protein 70 gene expression following exercise
Melling, C. W. J., Thorp, D. B., & Noble, E. G. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.021 · Cited by 37
LeBrasseur, N. K., Mizer, K., Parkington, J. D., et al. (2005) · European Journal of Applied Physiology · doi:10.1007/s00421-005-1333-4 · Cited by 23
Assessment of PI-3 Kinase and Akt in Ischemic Heart Diseases in Diabetes
Matsui, T., & Davidoff, A. J. (2007) · Methods in molecular medicine · doi:10.1007/978-1-59745-571-8_22 · Cited by 11
Breast Cancer: Clinical Decision Making
Levine, M. N., & Gafni, A. (1993) · PharmacoEconomics · doi:10.2165/00019053-199304030-00007 · Cited by 4
Cited by
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,544
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,795
Drug-induced oxidative stress and toxicity
Deavall, D. G., Martin, E. A., Horner, J. M., & Roberts, R. (2012) · Journal of Toxicology · doi:10.1155/2012/645460 · Cited by 689
Gorini, S., De Angelis, A., Berrino, L., Malara, N., Rosano, G., & Ferraro, E. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7582730 · Cited by 325
Chemotherapy-Induced Weakness and Fatigue in Skeletal Muscle: The Role of Oxidative Stress
Gilliam, L. A. A., & St. Clair, D. K. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3965 · Cited by 324
Metadata
- Authors
- Sawyer, D. B., Peng, X., Chen, B., Pentassuglia, L., & Lim, C. C.
- Venue
- Progress in Cardiovascular Diseases
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 53
- Issue
- 2
- Pages
- 105-113
- ISSN
- 0033-0620 (ISSN-L)
- OpenAlex
- W2033538830
- Cited by
- 270
- References
- 85
- FWCI
- 12.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.